Please login to the form below

Not currently logged in
Email:
Password:

Kaftrio

This page shows the latest Kaftrio news and features for those working in and with pharma, biotech and healthcare.

Vertex’s triple combination CF therapy to become available on the NHS

Vertex’s triple combination CF therapy to become available on the NHS

If the licence for Kaftrio is extended in the future, access to the triple therapy will become immediately available to these groups, said the NHS in a statement. ... The licensing of Kaftrio today marks a step change in the treatment of cystic fibrosis.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Understanding behaviour change: A Porterhouse Insights specialism
...
Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...